Tauns Laboratories Inc
197A
Company Profile
Business description
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia™ Flu Neo, Capilia™ Adeno Neo, Capilia™ RSV Neo, Capilia™ hMPV, etc.
Contact
761-1 Kamishima Izunokuni-shi
Shizuoka410-2325
JPNT: +81 558768181
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2026
Employees
446
Stocks News & Analysis
stocks
Weak investor sentiment for cheap ASX
Earnings growth maintained despite turbulent market conditions.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,983.90 | 25.20 | 0.28% |
| CAC 40 | 8,062.31 | 86.19 | 1.08% |
| DAX 40 | 24,401.70 | 410.43 | 1.71% |
| Dow JONES (US) | 49,298.25 | 356.35 | 0.73% |
| FTSE 100 | 10,219.11 | 144.82 | -1.40% |
| HKSE | 26,104.42 | 205.81 | 0.79% |
| NASDAQ | 25,326.13 | 258.33 | 1.03% |
| Nikkei 225 | 59,513.12 | 228.20 | 0.38% |
| NZX 50 Index | 13,131.00 | 95.30 | 0.73% |
| S&P 500 | 7,259.22 | 58.47 | 0.81% |
| S&P/ASX 200 | 8,762.20 | 27.20 | 0.31% |
| SSE Composite Index | 4,164.42 | 52.26 | 1.27% |